Medical
HPV Vaccination Disparities in UK: London’s Low Uptake
The UK Health Security Agency (UKHSA) has revealed significant disparities in HPV vaccination rates across England, with London showing the...
Read moreDetailsMHRA Strategic Shift: Patient Safety & Innovation
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has unveiled a new strategic direction under CEO Lawrence Tallon, focusing...
Read moreDetailsMedical Device Regulations: Enhancing Patient Safety in Great Britain
On 16 June 2025, Great Britain implemented new medical device regulations, enhancing post-market surveillance to improve patient safety and support...
Read moreDetailsUK Government Unveils 10 Year Health Plan
The UK government has unveiled a transformative 10 Year Health Plan, aiming to revolutionize clinical research by enabling millions to...
Read moreDetailsEnhanced Sickle Cell Treatment: NHS’s £9 Million Investment
Patients with sickle cell disease in England will soon benefit from enhanced treatment options thanks to a £9 million investment...
Read moreDetailsNHS Transformation: Bold Vision Unveiled
Health and Social Care Secretary Wes Streeting has unveiled a transformative vision for the NHS at NHS ConfedExpo 2025 in...
Read moreDetailsUK Government Invests £6 Billion in NHS
The UK government has unveiled a £6 billion investment in the NHS over five years, aiming to deliver up to...
Read moreDetailsOpenBind Consortium: Revolutionizing Drug Discovery
The UK government has launched the OpenBind consortium, backed by £8 million from the Sovereign AI Unit, to create the...
Read moreDetailsChikungunya Vaccine IXCHIQ Restrictions: Safety Measures
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has temporarily restricted the chikungunya vaccine IXCHIQ for those aged 65...
Read moreDetailsPreventive Healthcare Transformation: UK’s CST Advice
The UK’s Council for Science and Technology (CST) has advised the Prime Minister to focus on primary prevention to improve...
Read moreDetails
